Towards a novel influenza vaccine: engineering of hemagglutinin on a platform of adenovirus dodecahedron

BACKGROUND: The production process for the current influenza vaccine takes about 6 months and its antigenic composition must be modified annually. In the attempt towards developing influenza vaccine production that would be faster, safer and cheaper we engineered an influenza vaccine in which multip...

Descripción completa

Detalles Bibliográficos
Autores principales: Naskalska, Antonina, Szolajska, Ewa, Andreev, Igor, Podsiadla, Malgorzata, Chroboczek, Jadwiga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688493/
https://www.ncbi.nlm.nih.gov/pubmed/23767961
http://dx.doi.org/10.1186/1472-6750-13-50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688493/
https://www.ncbi.nlm.nih.gov/pubmed/23767961
http://dx.doi.org/10.1186/1472-6750-13-50

Ejemplares similares